Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sirolimus

EU orphan designation number: EU/3/17/1886   
Active ingredient: Sirolimus
Indication: Treatment of tuberous sclerosis
Sponsor: Vale Pharmaceuticals Limited
Unit 1B Gurtnafleur Business Park, Clonmel, Co. Tipperary, Ireland

  

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/06/2017 Orphan designation EMA/OD/007/17 (2017)4372 of 20/06/2017